What Is Sleep Study

Polysomnography is an overnight diagnostic test conducted in a sleep laboratory (or, in simplified form, at home) that simultaneously records brain electrical activity, eye movements, muscle tone, heart rhythm, airflow, respiratory effort, blood oxygen saturation, and limb movements during sleep. The data allow clinicians to identify specific sleep disorders, quantify their severity, and guide treatment decisions. It remains the reference standard for diagnosing conditions like obstructive sleep apnea, central sleep apnea, narcolepsy, and periodic limb movement disorder.

Sleep is not a passive state; it is the period during which the brain clears metabolic waste through the glymphatic system, consolidates memory, regulates hormones like growth hormone and cortisol, and repairs tissue. Disruptions to sleep architecture, whether from airway obstruction, abnormal limb movements, or neurological dysfunction, erode these restorative processes night after night. The cumulative damage touches nearly every system: cardiovascular disease risk rises, insulin sensitivity degrades, systemic inflammation increases, and cognitive function declines.

Because many sleep disorders present subtly (a person may not know they stop breathing forty times an hour), objective measurement becomes essential. Polysomnography provides granular data that subjective questionnaires and consumer wearables cannot replicate, particularly around respiratory events, arousal patterns, and sleep stage transitions. Identifying and treating a sleep disorder can reclaim years of restorative sleep, making polysomnography one of the highest-yield diagnostic investments in a longevity-oriented health strategy.

During an in-lab polysomnography, a technologist places a standardized array of sensors on the patient before bedtime. Electroencephalography (EEG) electrodes on the scalp record brain wave patterns that allow staging of sleep into N1, N2, N3 (slow-wave), and REM phases. Electrooculography (EOG) sensors near the eyes detect the rapid eye movements characteristic of REM sleep. Electromyography (EMG) leads on the chin and legs track muscle activity, which is critical for identifying REM behavior disorder and periodic limb movements.

Respiratory monitoring involves a nasal pressure transducer and oronasal thermistor to measure airflow, along with inductive plethysmography belts around the chest and abdomen to measure respiratory effort. A pulse oximeter on the finger continuously records blood oxygen saturation. Electrocardiography (ECG) captures heart rate and rhythm throughout the night. Some labs also record body position, snoring microphone data, and end-tidal or transcutaneous carbon dioxide levels when central hypoventilation is suspected.

All channels are recorded simultaneously onto a digital system, producing a continuous record called a polysomnogram. A trained technologist scores the data in 30-second epochs, classifying each epoch by sleep stage and flagging respiratory events (apneas, hypopneas, respiratory effort-related arousals), desaturations, limb movements, and cardiac arrhythmias. The scored report generates summary metrics, the most important of which is the apnea-hypopnea index (AHI), defined as the average number of apneas and hypopneas per hour of sleep. A sleep physician reviews the scored study, correlates it with clinical history, and determines a diagnosis.

Polysomnography simultaneously records six to eight physiological channels, each targeting a different dimension of sleep. Electroencephalography captures brain wave frequency and amplitude to classify sleep into stages N1 (light), N2 (intermediate), N3 (deep or slow-wave), and REM. Electrooculography detects eye movement onset and cessation, confirming REM periods. Chin and leg electromyography tracks muscle tone, identifying the atonia of REM and the repetitive limb jerks of periodic limb movement disorder.

Respiratory channels include nasal airflow (via pressure transducer), oral airflow (via thermistor), and chest and abdominal effort (via inductive plethysmography belts). Together, these distinguish obstructive events, where effort persists against a closed airway, from central events, where the brain temporarily stops sending the signal to breathe. Pulse oximetry records oxygen saturation continuously, flagging desaturation episodes and their nadir values. A single-lead ECG monitors heart rate and rhythm, and a body position sensor logs whether the patient is supine, lateral, or prone, which affects apnea severity.

The composite output is the polysomnogram, a multi-channel time-series spanning the entire night. From it, the scoring process generates key summary metrics: total sleep time, sleep efficiency (percentage of time in bed spent asleep), time and percentage in each sleep stage, AHI, oxygen desaturation index, lowest oxygen saturation, periodic limb movement index, and arousal index. These numbers form the diagnostic foundation.

Preparation is straightforward but matters for data quality. In the days before the study, maintain your usual sleep schedule; do not try to "bank" sleep or stay up extra late. Avoid alcohol for at least 24 hours before the test, as it alters REM distribution and upper airway tone. Stop caffeine intake by noon on the day of the study. Wash your hair that evening but skip conditioners, gels, and hairsprays, because the oily residue interferes with electrode adhesion on the scalp.

Bring comfortable, loose-fitting sleepwear (two-piece sets work best for electrode access) and any personal sleep aids you normally use, such as a specific pillow, though check with the lab first. If you take prescription medications, ask the ordering physician whether to take them as usual; certain sedatives, opioids, and muscle relaxants may need to be held or adjusted. Pack reading material or a device for the pre-sleep wait, since setup and lights-out times may differ from your typical bedtime. Arrive at the lab at the scheduled time, usually in the early evening, and expect the electrode application to take 30 to 45 minutes.

The report's most scrutinized number is the apnea-hypopnea index. An AHI below 5 events per hour is considered normal. An AHI of 5 to 14 indicates mild sleep apnea, 15 to 29 indicates moderate, and 30 or above indicates severe. However, AHI alone does not capture the full clinical picture. The oxygen desaturation index (how often saturation drops by 3% or more per hour) and the lowest recorded saturation provide additional severity information. A patient with an AHI of 12 but repeated desaturations below 80% may face greater cardiovascular risk than someone with an AHI of 20 and mild desaturations.

Sleep staging percentages reveal whether restorative sleep is adequate. In healthy adults, N3 (deep sleep) typically accounts for 15 to 25 percent of total sleep time, while REM makes up 20 to 25 percent. Low N3 may indicate chronic sleep fragmentation or age-related decline. A high arousal index (arousals per hour) suggests that even if total sleep time looks adequate, the brain is being repeatedly pulled toward wakefulness, degrading sleep quality. The periodic limb movement index flags whether leg movements are contributing to fragmentation independently of breathing events.

Your sleep physician will integrate these metrics with your symptoms and medical history. Treatment decisions follow from the pattern of findings: obstructive apnea typically leads to positive airway pressure therapy, an oral appliance, or positional therapy, while central apnea, narcolepsy, or limb movement disorders each have distinct management pathways.

For most people, a single diagnostic polysomnography paired with appropriate treatment is sufficient. A follow-up study (sometimes called a titration study) is often conducted to calibrate CPAP or BiPAP pressure settings, though some clinicians now use auto-titrating devices and skip this step. Repeat diagnostic testing is warranted if symptoms change significantly, if substantial weight gain or loss has occurred (which alters apnea severity), or if a patient develops new symptoms such as excessive sleepiness despite established treatment. After certain surgical interventions for apnea, a post-operative sleep study is commonly ordered to assess whether the procedure was effective. Outside of these clinical triggers, routine repeat polysomnography in the absence of symptom change is generally not necessary.

Polysomnography has been validated over decades of clinical use and is endorsed by major sleep medicine societies as the reference standard for diagnosing sleep-disordered breathing, narcolepsy, and parasomnias. Large epidemiological cohort studies have established strong associations between untreated obstructive sleep apnea (as defined by polysomnography metrics) and increased risk of hypertension, atrial fibrillation, stroke, type 2 diabetes, and all-cause mortality. Randomized controlled trials of CPAP therapy, prescribed on the basis of polysomnography findings, have shown reductions in blood pressure and daytime sleepiness, though the effect on hard cardiovascular endpoints like stroke and myocardial infarction has been less consistent in intention-to-treat analyses, partly due to adherence challenges.

Home sleep apnea testing has been studied against in-lab polysomnography in multiple comparative trials and performs well for diagnosing moderate to severe obstructive sleep apnea in patients with a high pre-test probability, though it tends to underestimate severity and misses non-respiratory sleep disorders entirely. Research gaps remain around the long-term prognostic value of specific polysomnographic features beyond AHI, such as hypoxic burden and arousal intensity, which newer scoring methods are beginning to quantify. There is also growing interest in whether repeat polysomnography after treatment initiation improves outcomes compared to clinical follow-up alone.

Polysomnography itself carries no physical risk; the sensors are passive recording devices that do not deliver energy to the body. The primary practical limitations are discomfort from the electrode array, the artificial sleeping environment of a lab, and the possibility that a single night may not represent typical sleep patterns (a phenomenon called the "first-night effect"). Insurance coverage for in-lab studies has tightened, and some payers require a home sleep test first. False negatives can occur, particularly with home tests, if the patient sleeps very little during the recording or if a positional component is missed. Interpretation quality depends on the scoring technologist and the reviewing physician, making it important to use an accredited sleep center.